Renal Cancer  >>  AlloStim (bioengineered allogeneic immune cells)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AlloStim (bioengineered allogeneic immune cells) / Immunovative
NCT00861107: In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation

Completed
1/2
50
US
AlloStim-7, Priming Phase, percutaneous tumor cryoablation, In-Situ Vaccine Phase, AlloStim8 or AlloStim-9, Immune activation phase
Immunovative Therapies, Ltd.
Metastatic Cancer
03/11
05/11

Download Options